ID   CD2_RAT                 Reviewed;         344 AA.
AC   P08921; F1M9W7; Q5I0M6;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   25-APR-2018, sequence version 2.
DT   24-JUL-2024, entry version 190.
DE   RecName: Full=T-cell surface antigen CD2;
DE   AltName: Full=LFA-2;
DE   AltName: Full=LFA-3 receptor;
DE   AltName: Full=OX-34 antigen {ECO:0000303|PubMed:3102667};
DE   AltName: Full=T-cell surface antigen T11/Leu-5;
DE   AltName: CD_antigen=CD2;
DE   Flags: Precursor;
GN   Name=Cd2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RC   STRAIN=AO;
RX   PubMed=3102667; DOI=10.1084/jem.165.2.368;
RA   Williams A.F., Barclay A.N., Clark S.J., Paterson D.J., Willis A.C.;
RT   "Similarities in sequences and cellular expression between rat CD2 and CD4
RT   antigens.";
RL   J. Exp. Med. 165:368-380(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND IDENTIFICATION.
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen {ECO:0000312|EMBL:AAH88164.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IMPORTANCE OF C-TERMINAL IN SIGNALING, AND FUNCTION.
RX   PubMed=2901293; DOI=10.1016/0092-8674(88)90112-2;
RA   He Q., Beyers A.D., Barclay A.N., Williams A.F.;
RT   "A role in transmembrane signaling for the cytoplasmic domain of the CD2 T
RT   lymphocyte surface antigen.";
RL   Cell 54:979-984(1988).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 23-198, AND DISULFIDE BONDS.
RX   PubMed=1279440; DOI=10.1038/360232a0;
RA   Jones E.Y., Davis S.J., Williams A.F., Harlos K., Stuart D.I.;
RT   "Crystal structure at 2.8-A resolution of a soluble form of the cell
RT   adhesion molecule CD2.";
RL   Nature 360:232-239(1992).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 23-121.
RX   PubMed=7638192; DOI=10.1073/pnas.92.16.7337;
RA   Murray A.J., Lewis S.J., Barclay A.N., Brady R.L.;
RT   "One sequence, two folds: a metastable structure of CD2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7337-7341(1995).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 23-121.
RX   PubMed=9731771; DOI=10.1038/1816;
RA   Murray A.J., Head J.G., Barker J.J., Brady R.L.;
RT   "Engineering an intertwined form of CD2 for stability and assembly.";
RL   Nat. Struct. Biol. 5:778-782(1998).
RN   [9]
RP   STRUCTURE BY NMR OF 23-121.
RX   PubMed=1682812; DOI=10.1038/353762a0;
RA   Driscoll P.C., Cyster J.G., Campbell I.D., Williams A.F.;
RT   "Structure of domain 1 of rat T lymphocyte CD2 antigen.";
RL   Nature 353:762-765(1991).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 121-199 IN COMPLEX WITH CD48,
RP   GLYCOSYLATION AT ASN-134, AND DISULFIDE BOND.
RX   PubMed=16803907; DOI=10.1074/jbc.m601314200;
RA   Evans E.J., Castro M.A., O'Brien R., Kearney A., Walsh H., Sparks L.M.,
RA   Tucknott M.G., Davies E.A., Carmo A.M., van der Merwe P.A., Stuart D.I.,
RA   Jones E.Y., Ladbury J.E., Ikemizu S., Davis S.J.;
RT   "Crystal structure and binding properties of the CD2 and CD244 (2B4)-
RT   binding protein, CD48.";
RL   J. Biol. Chem. 281:29309-29320(2006).
CC   -!- FUNCTION: CD2 interacts with lymphocyte function-associated antigen
CC       CD58 (LFA-3) and CD48/BCM1 to mediate adhesion between T-cells and
CC       other cell types. CD2 is implicated in the triggering of T-cells, the
CC       cytoplasmic domain is implicated in the signaling function.
CC       {ECO:0000269|PubMed:2901293}.
CC   -!- SUBUNIT: Interacts with CD48 (PubMed:16803907). Interacts with CD58
CC       (LFA-3) (By similarity). Interacts with CD2AP (By similarity).
CC       Interacts with PSTPIP1 (By similarity). Interacts with FCGR3A; this
CC       interaction modulates NK cell activation and cytotoxicity.
CC       {ECO:0000250|UniProtKB:P06729, ECO:0000250|UniProtKB:P08920,
CC       ECO:0000269|PubMed:16803907}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:3102667};
CC       Single-pass type I membrane protein {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X05111; CAA28757.1; -; mRNA.
DR   EMBL; AABR07012723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474015; EDL85525.1; -; Genomic_DNA.
DR   EMBL; BC088164; AAH88164.1; -; mRNA.
DR   PIR; A33071; RWRTC2.
DR   RefSeq; NP_036962.1; NM_012830.1.
DR   PDB; 1A64; X-ray; 2.00 A; A/B=23-121.
DR   PDB; 1A6P; X-ray; 2.08 A; A/B=26-121.
DR   PDB; 1A7B; X-ray; 3.10 A; A/B/C/D=23-121.
DR   PDB; 1CCZ; X-ray; 1.80 A; A=122-198.
DR   PDB; 1CDC; X-ray; 2.00 A; A/B=23-121.
DR   PDB; 1HNG; X-ray; 2.80 A; A/B=23-198.
DR   PDB; 1T6W; NMR; -; A=23-121.
DR   PDB; 2DRU; X-ray; 2.60 A; A=121-199.
DR   PDBsum; 1A64; -.
DR   PDBsum; 1A6P; -.
DR   PDBsum; 1A7B; -.
DR   PDBsum; 1CCZ; -.
DR   PDBsum; 1CDC; -.
DR   PDBsum; 1HNG; -.
DR   PDBsum; 1T6W; -.
DR   PDBsum; 2DRU; -.
DR   AlphaFoldDB; P08921; -.
DR   BMRB; P08921; -.
DR   SMR; P08921; -.
DR   IntAct; P08921; 1.
DR   MINT; P08921; -.
DR   STRING; 10116.ENSRNOP00000021268; -.
DR   GlyCosmos; P08921; 3 sites, No reported glycans.
DR   GlyGen; P08921; 3 sites.
DR   iPTMnet; P08921; -.
DR   PhosphoSitePlus; P08921; -.
DR   PaxDb; 10116-ENSRNOP00000021268; -.
DR   ABCD; P08921; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000021268.8; ENSRNOP00000021268.6; ENSRNOG00000015821.8.
DR   Ensembl; ENSRNOT00055033626; ENSRNOP00055027276; ENSRNOG00055019708.
DR   Ensembl; ENSRNOT00060021542; ENSRNOP00060017024; ENSRNOG00060012683.
DR   Ensembl; ENSRNOT00065055828; ENSRNOP00065045983; ENSRNOG00065032445.
DR   GeneID; 497761; -.
DR   KEGG; rno:497761; -.
DR   UCSC; RGD:2297; rat.
DR   AGR; RGD:2297; -.
DR   CTD; 914; -.
DR   RGD; 2297; Cd2.
DR   eggNOG; ENOG502S5UN; Eukaryota.
DR   GeneTree; ENSGT01030000234540; -.
DR   HOGENOM; CLU_069390_0_0_1; -.
DR   InParanoid; P08921; -.
DR   OMA; DIPNFQM; -.
DR   OrthoDB; 4584733at2759; -.
DR   PhylomeDB; P08921; -.
DR   EvolutionaryTrace; P08921; -.
DR   PRO; PR:P08921; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Proteomes; UP000234681; Chromosome 2.
DR   Bgee; ENSRNOG00000015821; Expressed in thymus and 17 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IMP:RGD.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0030101; P:natural killer cell activation; ISO:RGD.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISO:RGD.
DR   CDD; cd05775; IgV_CD2_like_N; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR015632; CD2.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR008424; Ig_C2-set.
DR   InterPro; IPR013106; Ig_V-set.
DR   PANTHER; PTHR12080; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE; 1.
DR   PANTHER; PTHR12080:SF54; T-CELL SURFACE ANTIGEN CD2; 1.
DR   Pfam; PF05790; C2-set; 1.
DR   Pfam; PF07686; V-set; 1.
DR   PRINTS; PR01870; CD2ANTIGEN.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Cell adhesion; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..22
FT   CHAIN           23..344
FT                   /note="T-cell surface antigen CD2"
FT                   /id="PRO_0000014603"
FT   TOPO_DOM        23..202
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        203..228
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        229..344
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          23..121
FT                   /note="Ig-like V-type"
FT   DOMAIN          122..202
FT                   /note="Ig-like C2-type"
FT   REGION          56..68
FT                   /note="CD58 binding region 1"
FT                   /evidence="ECO:0000250|UniProtKB:P06729"
FT   REGION          99..113
FT                   /note="CD58 binding region 2"
FT                   /evidence="ECO:0000250|UniProtKB:P06729"
FT   REGION          237..344
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        237..252
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        254..271
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        272..287
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        322..344
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        99
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        106
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16803907"
FT   DISULFID        132..196
FT                   /evidence="ECO:0000269|PubMed:1279440,
FT                   ECO:0000269|PubMed:16803907, ECO:0007744|PDB:1HNG"
FT   DISULFID        139..179
FT                   /evidence="ECO:0000269|PubMed:1279440,
FT                   ECO:0000269|PubMed:16803907, ECO:0007744|PDB:1HNG"
FT   CONFLICT        112
FT                   /note="N -> D (in Ref. 1; CAA28757)"
FT   STRAND          27..31
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          36..38
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          49..56
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          59..67
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          71..74
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          77..79
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          85..89
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   HELIX           92..94
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          96..104
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          109..120
FT                   /evidence="ECO:0007829|PDB:1A64"
FT   STRAND          127..131
FT                   /evidence="ECO:0007829|PDB:1CCZ"
FT   TURN            132..135
FT                   /evidence="ECO:0007829|PDB:1CCZ"
FT   STRAND          136..140
FT                   /evidence="ECO:0007829|PDB:1CCZ"
FT   STRAND          148..153
FT                   /evidence="ECO:0007829|PDB:1CCZ"
FT   STRAND          156..169
FT                   /evidence="ECO:0007829|PDB:1CCZ"
FT   STRAND          177..183
FT                   /evidence="ECO:0007829|PDB:1CCZ"
FT   STRAND          186..192
FT                   /evidence="ECO:0007829|PDB:1CCZ"
SQ   SEQUENCE   344 AA;  38413 MW;  FE2CB45CBF2E5FA5 CRC64;
     MRCKFLGSFF LLFSLSSKGA DCRDSGTVWG ALGHGINLNI PNFQMTDDID EVRWERGSTL
     VAEFKRKMKP FLKSGAFEIL ANGDLKIKNL TRDDSGTYNV TVYSTNGTRI LNKALDLRIL
     EMVSKPMIYW ECSNATLTCE VLEGTDVELK LYQGKEHLRS LRQKTMSYQW TNLRAPFKCK
     AVNRVSQESE MEVVNCPEKG LPLYLIVGVS AGGLLLVFFG ALFIFCICKR KKRNRRRKGE
     ELEIKASRMS TVERGPKPHS TQASAPASQN PVASQAPPPP GHHLQTPGHR PLPPSHRNRE
     HQPKKRPPPS GTQVHQQKGP PLPRPRVQPK PPCGSGDVSL PPPN
//
